New instrumentation offers advance for IOP measurement
September 11th 2005Lisbon, Portugal - Newer tonometry technology seems to offer an improvement on Goldmann tonometry, which has been the gold standard for measuring IOP during the last 50 years, said Jay Pepose, MD, PhD, professor of clinical ophthalmology and visual sciences, Washington University, School of Medicine, St. Louis, MO, United States.
New instrumentation offers advance for IOP measurement
September 11th 2005Lisbon, Portugal - Newer tonometry technology seems to offer an improvement on Goldmann tonometry, which has been the gold standard for measuring IOP during the last 50 years, said Jay Pepose, MD, PhD, professor of clinical ophthalmology and visual sciences, Washington University, School of Medicine, St. Louis, MO, United States.
What’s on the horizon for presbyopia: the refractive surgeon’s final frontier?
September 11th 2005Lisbon, Portugal - If presbyopia is the “final frontier” in refractive surgery, which surgical approach will stand out as the winner in treating patients with the condition? Will it be corneal surgery, intraocular surgery, or phakic-versus-pseudophakic approaches?
Tissue adhesive effective in total anterior lamellar keratoplasty
September 11th 2005Lisbon, Portugal - The use of fibrin glue seems to be effective and safe in total anterior lamellar keratoplasty (TALK), a procedure that completely exposes Descemet’s membrane within the area of host corneal trephination combined with transplantation of donor cornea without Descemet’s membrane and endothelium. Thomas John, MD, explained the procedure Sunday at the European Society of Cataract and Refractive Surgeons meeting.
Staged flap creation, ablation preferred for LASIK correction of high astigmatism post-PK
September 11th 2005Lisbon, Portugal - LASIK is an effective tool in the management of high astigmatism after penetrating keratoplasty (PK). Furthermore, a two-step technique may be preferred over a one-stage procedure because it allows for better evaluation of refractive changes induced by the keratectomy, said Ahmed Galal, MD, PhD.
ESCRS to handle administration of EURETINA
September 10th 2005Lisbon, Portugal – In an effort to create a synergy that will benefit all of the European ophthalmic community, the European Society of Cataract and Refractive Surgeons (ESCRS) and the European Society of Retina Specialists (EURETINA) have announced that the ESCRS will assume the administrative duties of the retina society.
Study finds no signs of toxicity with viscoanesthesia OVD
September 10th 2005Lisbon, Portugal – A viscoanesthesia-type of an ophthalmic viscosurgical device (OVD) did not show toxic or cataractogenic effects in rabbit eyes, according to a four-part study conducted at the Moran Eye Institute at the University of Utah, Salt Lake City, United States.
Blue-blocking IOLs may not be the panacea expected
September 10th 2005Lisbon, Portugal – Blue-blocking IOLs, which recently have been promoted as being vision protecting, may not be so. Martin Mainster, PhD, MD, of the University of Kansas Medical School, Kansas City, explained that the argument in favor of blue-blocking IOLs is theoretical at the European Society of Cataract and Refractive Surgeons.
ESCRS and ASCRS celebrate 10 years of co-editing cataract/refractive journal
September 10th 2005Lisbon, Portugal – The European Society of Cataract and Refractive Surgeons (ESCRS) and the American Society of Cataract and Refractive Surgery (ASCRS) celebrated 10 years of co-editing the Journal of Cataract and Refractive Surgery at the ESCRS Congress President’s Dinner on Friday night.
ESCRS to handle administration of EURETINA
September 10th 2005Lisbon, Portugal – In an effort to create a synergy that will benefit all of the European ophthalmic community, the European Society of Cataract and Refractive Surgeons (ESCRS) and the European Society of Retina Specialists (EURETINA) have announced that the ESCRS will assume the administrative duties of the retina society.
Tecnis IOL can provide spectacle-free vision after cataract surgery
September 10th 2005Lisbon, Portugal – Reading visual acuity and reading speed may depend of the type of IOL, according to one surgeon. Werner Huetz, MD, and colleagues compared three IOLs: the Array SA40N (AMO), the Tecnis ZM001 (AMO), and the AcrySof ReSTOR (Alcon Laboratories).
Address pupil ovalization after IOL implantation promptly
September 10th 2005Lisbon, Portugal – Pupil ovalization after implantation of IOLs is a rare occurrence. However, when it develops, it must be addressed immediately and effectively, according to Antonio Marinho, MD, PhD, of the University of Porto, Portugal.
Preventing PCO after cataract surgery in developing countries a goal
September 10th 2005Lisbon, Portugal – Cataract surgery in developing countries is a massive problem, but the cost of performing phacoemulsification in these countries is highly prohibitive. For that reason, extracapsular cataract surgery is performed with implantation of a polymethymethacrylate (PMMA) IOL.
PCO a living dynamic process after cataract surgery
September 10th 2005Lisbon, Portugal – Posterior capsule opacification (PCO) after cataract surgery is an evolving process, Oliver Findl, MD, from the Medical University of Vienna, Austria, explained Saturday at the European Society of Cataract and Refractive Surgeons.
Sealed capsule irrigation: new device to prevent PCO
September 10th 2005Lisbon, Portugal – Sealed capsule irrigation (SCI) using steroids in water is a new technique being studied that may prevent posterior capsular opacification (PCO) after cataract surgery. Gerd Auffarth, MD, PhD, from Heidelberg University Eye Clinic, Heidelberg, Germany, described this approach Saturday at the European Society of Cataract and Refractive Surgeons meeting.
Study results support use of rotating corneal autograft in traumatized eyes
September 1st 2005Washington, DC—Rotating corneal autograft offers a viable method for visual rehabilitation in highly traumatized eyes that are at risk for a poor outcome after penetrating keratoplasty (PK), said Sai Kolli, MD, at World Cornea Congress V.
Scleral lens an important tool in many 'last resort' scenarios
September 1st 2005Needham, MA—Outcomes achieved with the fluid-ventilated, gas-permeable Boston Scleral Lens (Boston Foundation for Sight) in approximately 1,000 eyes underscore its role as a valuable option for eyes with severe ocular surface disease and many other corneal disorders that would otherwise be candidates for penetrating keratoplasty, said Perry Rosenthal, MD.
Risk factors guide early treatment of ocular hypertension
September 1st 2005Fort Lauderdale, FL—Early treatment of ocular hypertension can decrease the incidence of primary open-angle glaucoma. Risk factors can be assessed relatively simply in the office to identify patients at high and low risk of developing glaucoma, Michael Kass, MD, said.
Deep sclerectomy, trabeculectomy effectively lower IOP
September 1st 2005Fort Lauderdale, FL—A comparison of penetrating with non-penetrating glaucoma surgery, specifically deep sclerectomy and trabeculectomy, indicated that the latter provided better control of IOP 7 years after the surgery, according to Stefano Gandolfi, MD. When deep sclerectomy was converted to a penetrating procedure, the surgical success rate increased significantly.
UCSB makes important advances in RD studies
September 1st 2005Santa Barbara, CA—Scientists at the University of California, Santa Barbara (UCSB), have made discoveries that could lead to improved recovery after retinal reattachment surgery and inhibition of undesirable cellular effects that lead to proliferative vitreoretinopathy (PVR).
Follow-up intravitreal triamcinolone improves PDT results
September 1st 2005Montreal—Combination treatment of neovascular age-related macular degeneration (AMD) using verteporfin photodynamic therapy (Visudyne PDT, Novartis/QLT Inc.) plus intravitreal triamcinolone acetonide appears to improve visual outcomes and reduce the number of re-treatments necessary to achieve lesion regression compared with standard PDT alone, albeit with the recognized steroid-associated risks of cataract progression and IOP elevation, said Albert J. Augustin, MD, at the annual meeting of the American Society of Retina Specialists.